The latest closing stock price for MoonLake Immunotherapeutics as of March 03, 2025 is 39.71.
An investor who bought $1,000 worth of MoonLake Immunotherapeutics stock at the IPO in 2020 would have $2,786 today, roughly 3 times their original investment - a 39.49% compound annual growth rate over 4 years.
The all-time high MoonLake Immunotherapeutics stock closing price was 63.86 on February 12, 2024.
The MoonLake Immunotherapeutics 52-week high stock price is 58.26, which is 46.7% above the current share price.
The MoonLake Immunotherapeutics 52-week low stock price is 37.55, which is 5.4% below the current share price.
The average MoonLake Immunotherapeutics stock price for the last 52 weeks is 46.60.
An investor who bought $1,000 worth of MoonLake Immunotherapeutics stock at the IPO in 2020 would have $2,786 today, roughly 3 times their original investment - a 39.49% compound annual growth rate over 4 years.
The all-time high MoonLake Immunotherapeutics stock closing price was 63.86 on February 12, 2024.
The MoonLake Immunotherapeutics 52-week high stock price is 58.26, which is 46.7% above the current share price.
The MoonLake Immunotherapeutics 52-week low stock price is 37.55, which is 5.4% below the current share price.
The average MoonLake Immunotherapeutics stock price for the last 52 weeks is 46.60.